| mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |